Skip to Main Content

Paper Details

Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study.
2
2023
CANDOR, Kd, KdD, Patients, RRMM, carfilzomib, daratumumab, dexamethasone, lenalidomide, patient, patients
Author NameAffiliation
David S SiegelJohn Theurer Cancer Center at Hackensack University Medical Center
Xiao-Ou Shu
  • 1 - 2

Datasets

Release 1.2